- Home
- XPER vs ORGO Comparison
XPER vs ORGO Comparison
Compare XPER & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPER
- ORGO
- Stock Information
- Founded
- XPER 1990
- ORGO 1985
- Country
- XPER United States
- ORGO United States
- Employees
- XPER N/A
- ORGO N/A
- Industry
- XPER Semiconductors
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- XPER Technology
- ORGO Health Care
- Exchange
- XPER Nasdaq
- ORGO Nasdaq
- Market Cap
- XPER 463.5M
- ORGO 533.9M
- IPO Year
- XPER 2003
- ORGO N/A
- Fundamental
- Price
- XPER $8.33
- ORGO $3.15
- Analyst Decision
- XPER Strong Buy
- ORGO Buy
- Analyst Count
- XPER 3
- ORGO 2
- Target Price
- XPER $19.00
- ORGO $5.50
- AVG Volume (30 Days)
- XPER 380.9K
- ORGO 2.1M
- Earning Date
- XPER 05-07-2025
- ORGO 05-08-2025
- Dividend Yield
- XPER N/A
- ORGO N/A
- EPS Growth
- XPER N/A
- ORGO N/A
- EPS
- XPER N/A
- ORGO N/A
- Revenue
- XPER $488,877,000.00
- ORGO $458,760,000.00
- Revenue This Year
- XPER $0.74
- ORGO $3.31
- Revenue Next Year
- XPER $8.45
- ORGO $12.50
- P/E Ratio
- XPER N/A
- ORGO N/A
- Revenue Growth
- XPER N/A
- ORGO 5.35
- 52 Week Low
- XPER $6.29
- ORGO $2.17
- 52 Week High
- XPER $11.08
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- XPER 68.80
- ORGO 31.96
- Support Level
- XPER $6.36
- ORGO $2.90
- Resistance Level
- XPER $8.50
- ORGO $5.55
- Average True Range (ATR)
- XPER 0.26
- ORGO 0.40
- MACD
- XPER 0.18
- ORGO -0.21
- Stochastic Oscillator
- XPER 89.17
- ORGO 10.11
About XPER Xperi Inc.
Xperi Inc consumer and entertainment technology company. Its offering comprises a portfolio of software and services. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.